Microbiologically documented nosocomial infections after coronary artery bypass surgery without cardiopulmonary bypass

Journal of Thoracic and Cardiovascular Surgery

Volumn 132, Issue 3, 2006, Pages 481-490

  Falagas, Matthew E ^a,b,c   Rosmarakis, Evangelos S ^a   Rellos, Konstantinos ^a,b   Michalopoulos, Argyris ^a,b   Samonis, George ^d   Prapas, Sotirios N ^b  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b HENRY DUNANT HOSPITAL   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFUROXIME; CORTICOSTEROID; FRESH FROZEN PLASMA; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; BACTEREMIA; CANDIDA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DECUBITUS; DISEASE ASSOCIATION; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEART ATRIUM FIBRILLATION; HOSPITAL INFECTION; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; MALE; MEDIASTINITIS; MICROBIOLOGY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; OFF PUMP CORONARY SURGERY; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; STERNOTOMY; URINARY TRACT INFECTION; VASCULAR SURGERY; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY BYPASS, OFF-PUMP; CROSS INFECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33747792455     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.05.019     Document Type: Article

References (21)

1. Menasche P. The systemic factor. the comparative roles of cardiopulmonary bypass and off-pump surgery in the genesis of patient injury during and following cardiac surgery. Ann Thorac Surg 72 (2001) S2260-S2270
2. Ascione R., Lloyd C.T., Underwood M.J., Lotto A.A., Pitsis A.A., and Angelini G.D. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 69 (2000) 1198-1204
3. Cheng D.C., Bainbridge D., Martin J.E., Novick R.J., and Evidence-Based Perioperative Clinical Outcomes Research Group. Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology 102 (2005) 188-203
4. Mack M.J., Pfister A., Bachand D., Emery R., Magee M.J., Connolly M., et al. Comparison of coronary bypass surgery with and without cardiopulmonary bypass in patients with multivessel disease. J Thorac Cardiovasc Surg 127 (2004) 167-173
5. Prapas S.N., Anagnostopoulos C.E., Kotsis V.N., Stavropoulos G.P., Sidiropoulos A.V., Ananiadou O.G., et al. A new pattern for using both thoracic arteries to revascularize the entire heart. the π-graft. Ann Thorac Surg 73 (2002) 1990-1992
6. Horan T.C., and Gaynes R.P. Surveillance of nosocomial infections. Appendix A: CDC definitions of nosocomial infections. In: Mayahall C.G. (Ed). Hospital epidemiology and infection control (2004), Lippincot Williams & Wilkins, Philadelphia 1659-1702
7. Fowler Jr. V.G., O'Brien S.M., Muhlbaier L.H., Corey G.R., Ferguson T.B., and Peterson E.D. Clinical predictors of major infections after cardiac surgery. Circulation 112 9 Suppl (2005) I358-I365
8. Kollef M.H., Sharpless L., Vlasnik J., Pasque C., Murphy D., and Fraser V.J. The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest 112 (1997) 666-675
9. Gol M.K., Karahan M., Ulus A.T., Erdil N., Iscan Z., Karabiber N., et al. Bloodstream, respiratory, and deep surgical wound infections after open heart surgery. J Card Surg 13 (1998) 252-259
10. Almassi G.H., Schowalter T., Nicolosi A.C., Aggarwal A., Moritz T.E., Henderson W.G., et al. Atrial fibrillation after cardiac surgery. a major morbid event?. Ann Surg 226 (1997) 501-511
11. Elahi M., Hadjinikolaou L., and Galinanes M. Incidence and clinical consequences of atrial fibrillation within 1 year of first-time isolated coronary bypass surgery. Circulation 108 Suppl 1 (2003) II207-II212
12. Bender J.S. Supraventricular tachyarrhythmias in the surgical intensive care unit. an under-recognized event. Am Surg 62 (1996) 73-75
13. Engelmann M.D., and Svendsen J.H. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 26 (2005) 2083-2092
14. Wazni O., Martin D.O., Marrouche N.F., Shaaraoui M., Chung M.K., Almahameed S., et al. C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion. Heart 91 (2005) 1303-1305
15. Abdelhadi R.H., Gurm H.S., Van Wagoner D.R., and Chung M.K. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol 93 (2004) 1176-1178
16. Ryan T., Mc Carthy J.F., Rady M.Y., Serkey J., Gordon S., Starr N.J., et al. Early bloodstream infection after cardiopulmonary bypass. frequency rate, risk factors, and implications. Crit Care Med 25 (1997) 2009-2014
17. Michalopoulos A., Stavridis G., and Geroulanos S. Severe sepsis in cardiac surgical patients. Eur J Surg 164 (1998) 217-222
18. Sreeram G.M., Welsby I.J., Sharma A.D., Phillips-Bute B., Smith P.K., and Slaughter T.F. Infectious complications after cardiac surgery. lack of association with fresh frozen plasma or platelet transfusions. J Cardiothorac Vasc Anesth 19 (2005) 430-434
19. Michalopoulos A., Geroulanos S., Rosmarakis E.S., and Falagas M.E. Frequency, characteristics, and predictors of microbiologically documented nosocomial infections after cardiac surgery. Eur J Cardiothorac Surg 29 (2006) 456-460
20. Bratzler D.W., Houck P.M., and Surgical Infection Prevention Guidelines Writers Workgroup. Antimicrobial prophylaxis for surgery. an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38 (2004) 1706-1715
21. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 56 (1999) 1839-1888